REDWOOD CITY, Calif., Sept. 22, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective September 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 109,000 shares of the common stock of the Company…Read More
Coherus BioSciences Inc Coherus BioSciences Announces New Employment Inducement Grants
